HABA Laboratories, Inc.(JP:4925)
Â¥1,650.00-1.00 (-0.06%)
JP:4925
HABA Laboratories, Inc. financials statements
Â¥1,650.00
At close:-1.00 (-0.06%)
Want to see JP:4925 full AI Analyst Report?
HABA Laboratories, Inc. (4925) Ratios
1 Followers
HABA Laboratories, Inc. Ratios
JP:4925's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:4925's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.17 | 3.40 | 3.23 | 3.34 | 3.98 |
| Quick Ratio | 3.07 | 2.30 | 1.91 | 2.14 | 2.73 |
| Cash Ratio | 2.47 | 1.78 | 1.41 | 1.72 | 2.23 |
| Solvency Ratio | 0.32 | 0.22 | -0.41 | -0.04 | 0.11 |
| Operating Cash Flow Ratio | 0.53 | 0.61 | -0.21 | 0.02 | 0.68 |
| Short-Term Operating Cash Flow Coverage | 2.13 | 1.49 | -0.43 | 0.06 | 1.58 |
| Net Current Asset Value | ¥ 6.80B | ¥ 5.62B | ¥ 5.15B | ¥ 5.46B | ¥ 6.02B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.15 | 0.19 | 0.14 | 0.16 |
| Debt-to-Equity Ratio | 0.12 | 0.20 | 0.28 | 0.19 | 0.22 |
| Debt-to-Capital Ratio | 0.11 | 0.17 | 0.22 | 0.16 | 0.18 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.08 | 0.11 | 0.09 | 0.11 |
| Financial Leverage Ratio | 1.31 | 1.38 | 1.46 | 1.36 | 1.35 |
| Debt Service Coverage Ratio | 1.35 | 0.68 | -1.17 | -0.14 | 0.41 |
| Interest Coverage Ratio | 42.32 | 34.63 | -19.30 | -100.68 | -44.17 |
| Debt to Market Cap | 0.18 | 0.28 | 0.30 | 0.23 | 0.31 |
| Interest Debt Per Share | 318.52 | 484.98 | 625.36 | 539.17 | 678.31 |
| Net Debt to EBITDA | -5.12 | -3.61 | 1.22 | -163.39 | -6.90 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.52% | 66.28% | 65.12% | 67.86% | 68.13% |
| EBIT Margin | 5.87% | 5.41% | -14.88% | -4.51% | -2.01% |
| EBITDA Margin | 7.40% | 6.73% | -10.66% | 0.14% | 3.47% |
| Operating Profit Margin | 5.87% | 4.89% | -1.52% | -5.06% | -2.45% |
| Pretax Profit Margin | 7.00% | 5.27% | -14.96% | -4.56% | -2.07% |
| Net Profit Margin | 6.26% | 4.78% | -17.19% | -5.88% | -2.08% |
| Continuous Operations Profit Margin | 6.26% | 4.78% | -17.19% | -5.88% | -2.08% |
| Net Income Per EBT | 89.45% | 90.69% | 114.94% | 129.02% | 100.78% |
| EBT Per EBIT | 119.35% | 107.84% | 981.69% | 90.00% | 84.28% |
| Return on Assets (ROA) | 6.07% | 4.67% | -17.04% | -4.83% | -1.72% |
| Return on Equity (ROE) | 7.97% | 6.46% | -24.90% | -6.57% | -2.31% |
| Return on Capital Employed (ROCE) | 7.00% | 6.09% | -1.95% | -5.14% | -2.41% |
| Return on Invested Capital (ROIC) | 5.92% | 4.96% | -1.71% | -4.74% | -2.22% |
| Return on Tangible Assets | 6.13% | 4.71% | -17.04% | -4.94% | -1.75% |
| Earnings Yield | 11.82% | 8.76% | -26.99% | -8.03% | -3.29% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.69 | 10.09 | 9.79 | 12.34 | 11.47 |
| Payables Turnover | 12.94 | 17.17 | 14.18 | 8.13 | 12.24 |
| Inventory Turnover | 1.63 | 1.39 | 1.16 | 1.15 | 1.31 |
| Fixed Asset Turnover | 5.11 | 4.06 | 4.17 | 2.70 | 2.77 |
| Asset Turnover | 0.97 | 0.98 | 0.99 | 0.82 | 0.82 |
| Working Capital Turnover Ratio | 1.76 | 1.91 | 1.92 | 1.71 | 1.68 |
| Cash Conversion Cycle | 233.63 | 277.07 | 326.86 | 302.42 | 281.60 |
| Days of Sales Outstanding | 37.68 | 36.18 | 37.27 | 29.57 | 31.83 |
| Days of Inventory Outstanding | 224.15 | 262.14 | 315.33 | 317.71 | 279.59 |
| Days of Payables Outstanding | 28.20 | 21.25 | 25.73 | 44.87 | 29.82 |
| Operating Cycle | 261.83 | 298.32 | 352.60 | 347.28 | 311.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 327.17 | 428.67 | -155.47 | 14.80 | 453.37 |
| Free Cash Flow Per Share | 306.91 | 392.10 | -270.05 | -61.53 | 403.79 |
| Dividend Paid and CapEx Coverage Ratio | 5.42 | 5.60 | -1.01 | 0.13 | 5.06 |
| Capital Expenditure Coverage Ratio | 16.15 | 11.72 | -1.36 | 0.19 | 9.14 |
| Operating Cash Flow Coverage Ratio | 1.04 | 0.89 | -0.25 | 0.03 | 0.67 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.13 | -0.05 | 0.00 | 0.13 |
| Free Cash Flow Yield | 18.04% | 22.53% | -13.01% | -2.64% | 18.69% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 8.46 | 11.41 | -3.71 | -12.45 | -30.38 |
| Price-to-Sales (P/S) Ratio | 0.53 | 0.55 | 0.64 | 0.73 | 0.63 |
| Price-to-Book (P/B) Ratio | 0.67 | 0.74 | 0.92 | 0.82 | 0.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.54 | 4.44 | -7.69 | -37.86 | 5.35 |
| Price-to-Operating Cash Flow Ratio | 5.20 | 4.06 | -13.35 | 157.46 | 4.77 |
| Price-to-Earnings Growth (PEG) Ratio | 0.27 | -0.09 | -0.02 | -0.08 | 0.14 |
| Enterprise Value Multiple | 2.04 | 4.50 | -4.75 | 353.53 | 11.33 |
| Enterprise Value | 1.84B | 3.65B | 6.25B | 6.03B | 5.08B |
| EV to EBITDA | 2.04 | 4.50 | -4.75 | 353.53 | 11.33 |
| EV to Sales | 0.15 | 0.30 | 0.51 | 0.50 | 0.39 |
| EV to Free Cash Flow | 1.58 | 2.46 | -6.12 | -25.90 | 3.33 |
| EV to Operating Cash Flow | 1.48 | 2.25 | -10.62 | 107.69 | 2.96 |
| Tangible Book Value Per Share | 2492.03 | 2336.01 | 2249.65 | 2765.52 | 2985.95 |
| Shareholders’ Equity Per Share | 2521.82 | 2360.72 | 2249.65 | 2849.03 | 3077.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.11 | 0.09 | -0.15 | -0.29 | -0.01 |
| Revenue Per Share | 3210.73 | 3189.68 | 3259.06 | 3183.39 | 3413.65 |
| Net Income Per Share | 201.07 | 152.47 | -560.26 | -187.19 | -71.14 |
| Tax Burden | 0.89 | 0.91 | 1.15 | 1.29 | 1.01 |
| Interest Burden | 1.19 | 0.97 | 1.01 | 1.01 | 1.03 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.59 | 0.60 | 0.35 | 0.36 | 0.34 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.63 | 2.81 | 0.28 | -0.10 | -6.42 |
Currency in JPY

